ATRI | Atrion Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	459.75 - 460.26
52 Week Range	274.98 - 503.24
Beta	0.76
Implied Volatility	N/A
IV Rank	N/A
Day's Volume	29,517
Average Volume	27,595
Shares Outstanding	1,759,950
Market Cap	809,436,204
Sector	Healthcare
Industry	Medical - Instruments & Supplies
IPO Date	1980-03-18

Valuation
Profitability
Growth
Health
P/E Ratio	64.50
Forward P/E Ratio	N/A
EPS	7.13
1YR Price Target	N/A
Dividend Yield	1.91%
Dividend Per Share	5.40
Dividend ExDate	2023-03-14
Dividend PayDate	2023-03-31
Employees	712
Country	USA
Website	ATRI

Atrion Corp develops and manufactures products for medical applications.

ATRI's peers: AKYA, ANGO, ZTEK, ATR, ATRC, AVGR, AZTA, BLFS, EKSO, HAE, ICUI, KRMD, LMAT, NHC, NVST, OMIC, OSUR, PDEX, PLSE, WRBY, EMBC, BLCO

*Chart delayed

Analyzing fundamentals for ATRI we got that it has weak fundamentals where Valuation is considered to be slightly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is passable. For more detailed analysis please see ATRI Fundamentals page.

Watching at ATRI technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ATRI Technicals page.